Abstract: The present application includes a compound of Formula I or II: or a pharmaceutically acceptable-salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.
Abstract: A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating compound (1) are provided.
Type:
Grant
Filed:
February 18, 2010
Date of Patent:
June 7, 2011
Assignees:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Steven S. Bondy, David A. Oare, Winston C. Tse
Abstract: A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections Methods of making and formulating compound (1) are provided.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
July 13, 2010
Assignees:
Gilead Sciences, Inc., K.U. Leuven Research & Development, Gerhard Puerstinger
Inventors:
Steven S. Bondy, Terrence C. Dahl, David A. Oare, Reza Oliyai, Winston C. Tse, Vahid Zia